|Bid||6.01 x 100|
|Ask||8.50 x 9800|
|Day's Range||7.62 - 8.43|
|52 Week Range||4.41 - 9.61|
|PE Ratio (TTM)||-5.52|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||12.07|
CRANBURY, N.J., May 19, 2017-- Amicus Therapeutics, Inc., has completed the analysis plan for the primary endpoints in the blinded ongoing Phase 3 clinical study of the novel topical medicine SD-101 for ...
NEW YORK, NY / ACCESSWIRE / May 18, 2017 / Despite the recent sell-off triggered by the recent health-care bill that is meant to take the place of the Affordable Care Act, the Biotech Industry has continued ...
Mean Six-Minute Walk Distance at Month Six Improved in ERT-Naïve Patients and ERT-Switch Patients. Muscle Function Improved in 9 out of 10 Patients. Pulmonary Function Improved in a Majority of Patients....